SITS UTMOST

Summary

A registry-based study dedicated to the use of intravenousthrombolysis by rt-PA in treatment of acute ischaemic stroke patients.

Status: Initiated
Type of study: A prospective, post-approval registry study of intravenous rt-PA (0.9 mg/kg) up to 4.5 hours of symptom onset in acute ischaemic stroke patients
Location: European Union

"SITS-UTMOST - A prospective, post-approval registry study of intravenous rt-PA (0.9 mg/kg) up to 4.5 hours after symptom onset in acute ischaemic stroke patients. The study has been completed and the main results of are currently in preparation for publication."